% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 4

Loading Chart...

8 inventors (with patents filed for the assignee):

Richard A Bond (2 out of 4 patents)

Christopher Bruce Howard (2 out of 7 patents)

Barbara Jane Johnson (2 out of 6 patents)

4. Caroline Amanda Dobbin (2 out of 6 patents)

5. Linda Allison Ward (2 out of 5 patents)

6. Mitchell Glass (1 out of 4 patents)

7. Dean Jason Naylor (1 out of 6 patents)

8. Dean Jason Taylor (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 9993444 - Use of beta-adrenergic inverse agonists for smoking cessation (2018-06-12),

2. 9539221 - Method of treating airway diseases with β-adrenergic inverse agonists (2017-01-10),

3. 9079967 - Modified chaperonin 10 (2015-07-14),

4. 8513201 - Modified chaperonin 10 (2013-08-20),

Invion Limited is a specialty pharmaceutical company focused on the development of treatments for chronic inflammatory and respiratory diseases. Their primary product, INV102 (nadolol), is in development for the treatment of bronchiectasis and chronic obstructive pulmonary disease (COPD). The company is also exploring other potential therapies in the areas of inflammation and respiratory diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1 in Seventeen Mile Rocks

#1,029 in Australia

Seventeen Mile Rocks, Australia

Invion Limited